First Allied Asset Management’s AstraZeneca AZN Stock Holding History

First Allied Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-91,066	Closed	-$5.43M	–	173
2013 Q4	$5.43M	Buy	91,066 +3,446	+4%	+$187K	0.78%	62
2013 Q3	$4.59M	Buy	87,620 +7,591	+9%	+$381K	0.69%	65
2013 Q2	$3.79M	Buy	+80,029	New	+$4.08M	0.55%	68

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

First Allied Asset Management's AZN Position: Q1 2014 in Review

First Allied Asset Management sold out of AstraZeneca (AZN) in Q1 2014, closing a stake of 91,066 shares — an estimated $5.43M sold.

First Allied Asset Management first reported a position in AZN in Q2 2013 and held it in 3 quarters. The position peaked at $5.43M in Q4 2013. 388 funds tracked by Wall St. Rank hold AZN as of Q1 2014.

First Allied Asset Management reported no remaining AstraZeneca position as of Q1 2014 after selling out during the quarter.
First Allied Asset Management sold 91,066 AstraZeneca shares in Q1 2014, an estimated $5.43M.
First Allied Asset Management first reported a position in AstraZeneca in Q2 2013 and held it in 3 quarters.
First Allied Asset Management's AstraZeneca position peaked at $5.43M in Q4 2013.
388 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2014.

Based on First Allied Asset Management's 13F filing for Q1 2014, filed 14 May 2014.